Online Share Trading for beginners and professional traders. You have a choice to manage your own portfolio or you can choose to have us manage it for you.
Sygnia Asset Management is developing a new vaccine and South Africans are once again connecting the dots between CEO Magda Wierzycka and President Cyril Ramaphosa.
Sygnia, an investor in Oxford Sciences Innovation, approached the Serum Institute of India (SII) to run trials on a new set of jabs. The aim is to produce 10 million inoculations for South Africa citizens.
Magda Wierzycka, Ramaphosa and the vaccine
Vaccine battle
Earlier this week, Wierzycka told
Moneyweb editor Ryk van Niekerk that the Ministry of Health should use AstraZeneca on medical personnel in order to have a “larger sample size to observe on a live basis”.